Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma

Digestion

Volumn 75, Issue 2-3, 2007, Pages 104-112

  Helmberger, Thomas ^a   Dogan, Selin ^b   Straub, Gundula ^b   Schrader, Angelika ^a   Jüngst, Christoph ^c   Reiser, Maximilian ^b   Waggershauser, Tobias ^b   Jakobs, Tobias ^b   Hoffmann, Ralf Thorsten ^b   Löhe, Florian ^b   Graeb, Christian ^b   Rau, Horst Günter ^d   Schauer, Rolf ^e   Jauch, Karl Walter ^b   Caselmann, Wolfgang H ^f   Göke, Burkhard ^b   Jüngst, Dieter ^b  

^a UNIVERSITY OF LÜBECK   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d Amper Kliniken AG   (Germany)

^e Klinikum Traunstein   (Germany)

^f Bavarian State Ministry of the Environment   (Germany)

Author keywords

Liver resection; Long term follow up; Non surgical minimally invasive treatment; Vienna survival model for hepatocellular carcinoma

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SINGLE DRUG DOSE; STATISTICAL MODEL; SURVIVAL; SURVIVAL TIME; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34548311863     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104730     Document Type: Article

References (46)

1. Bosch FX, Ribes J, Borras J: Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-285.
2. Befeler AS, di Bisceglie AM: Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002;122:1609-1619.
3. Llovet JM, Burroughs A, Bruix J: Hepatocellular carcinoma. Lancet 2003;362:1907-1917.
4. Kim WR, Gores GJ, Benson JT, Therneau TM, Melton LJ III: Mortality and hospital utilization for hepatocellular carcinoma in the United States. Gastroenterology 2005;129:486-493.
5. Sasaki Y, Imaoka S, Masutani S, Ohashi I, Ishikawa O, Koyama H, Iwanaga T: Influence of coexisting cirrhosis on long-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 1992;112:515-521.
6. Tan KC, Rela M, Ryder SD, Rizzi PM, Karani J, Portmann B, Heaton ND, et al: Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma less than 8 cm in patients with cirrhosis. Br J Surg 1995;82:253-256.
7. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T, Itasaka H, Shirabe K, et al: Results of 280 liver resections for hepatocellular carcinoma. Arch Surg 1996;131:71-76.
8. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, Ayuso C, et al: Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology 1993;18:1121-1126.
9. Kotoh K, Sakai H, Sakamoto S, Nakayama S, Satoh M, Morotomi I, Nawata H: The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy. Am J Gastroenterol 1994;89:194-198.
10. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire: A comparison of lipiodol chemoembolization and conservative treatment for unresectable HCC. N Engl J Med 1995;332:1256-1261.
11. Livraghi T, Giorgio A, Marin G, Salmi A, de Sio I, Bolondi L, Pompili M, et al: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995;197:101-108.
12. Rossi S, Di Stasi M, Buscarini E, Quaretti P, Garbagnati F, Squassante L, Paties CT, et al: Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer. AJR Am J Roentgenol 1996;167:759-768.
13. Allgaier HP, Deibert P, Olschewski M, Spamer C, Blum U, Gerok W, Blum HE: Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolisation and percutaneous ethanol injection - a single center analysis including 132 patients. Int J Cancer 1998;79:601-605.
14. Goldberg SN, Gazelle GS, Solbiati L, Livraghi T, Tanabe KK, Hahn PF, Mueller PR, et al: Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol 1998;170:1023-1028.
15. Rossi S, Buscarini E, Garbagnati F, Di Stasi M, Quaretti P, Rago M, Zangrandi A, et al: Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998;170:1015-1022.
16. Pelletier G, Ducreux M, Gay F, Luboinski M, Hagege H, Dao T, van Steenbergen W, et al: Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC. J Hepatol 1998;29:129-134.
17. Bruix J, Llovet JM, Castells A, Montana X, Bru C, Ayuso MC, Vilana R, et al: Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 1998;27:1578-1583.
18. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS: Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655-661.
19. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, Makuuchi M, et al: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000;32:1224-1229.
20. Curley SA, Izzo F, Ellis LM, Nicolas VJ, Vallone P: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000;232:381-391.
21. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle GS: Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000;214:761-768.
22. Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A: Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001;11:914-921.
23. Bowles BJ, Machi J, Limm WM, Severino R, Oishi AJ, Furumoto NL, Wong LL, et al: Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors. Arch Surg 2001;136:864-869.
24. Lencioni R, Cioni D, Bartolozzi C: Percutaneous radiofrequency thermal ablation of liver malignancies: techniques, indications, imaging findings, and clinical results. Abdom Imaging 2001;26:345-360.
25. Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J: Small hepatocellular carcinoma: comparison of radiofrequency ablation and percutaneous microwave coagulation therapy. Radiology 2002;223:331-337.
26. Llovet JM, Real MI, Montana X, Planas R, Coll S, Aponte J, Ayuso C, et al for the Barcelona Clinic Liver Cancer Group: Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734-1739.
27. Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M: Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002;62:64-68.
28. Llovet JM, Bruix J: Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003;37:429-442.
29. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, Ishikawa T, et al: A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122-130.
30. Takayasu K, Arii S, Ikai I, Omata M, Okita K, Ichida T, Matsuyama Y, et al: Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8,510 patients. Gastroenterology 2006;131:461-469.
31. Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, et al: Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy. Am Surg 2002;68:827-831.
32. Schöniger-Hekele M, Müller C, Kutilek M, Oesterreicher C, Ferenci P, Gangl A: Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut 2001;48:103-109.
33. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, et al: Clinical management of hepatocellular carcinoma: conclusions of the Barcelona 2000 EASL Conference. J Hepatol 2001;35:421-430.
34. Curley SA, Izzo F: Radiofrequency ablation of hepatocellular carcinoma. Minerva Chir 2002;57:165-176.
35. Johnson PJ: Hepatocellular carcinoma: is current therapy really altering outcome? Gut 2002;51:459-462.
36. Rabe C, Lenz M, Schmitz V, Pilz T, Fimmers R, Sauerbruch T, Caselmann WH: An independent evaluation of modern prognostic scores in a Central European cohort of 120 patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2003;15:1305-1315.
37. Befeler AS, Hayashi PH, Di Bisceglie AM: Liver transplantation for hepatocellular carcinoma. Gastroenterology 2005;128:1752-1764.
38. Sangiovanni A, Del Ninno E, De Fazio C, Ronchi G, Romeo R: Increased survival of cirrhosis patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology 2004;126:1005-1014.
39. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, Visa J, et al: Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996;111:1018-1022.
40. Franco D, Capussotti L, Smadja C, Bonzari H, Meakins J, Kemeny F, Grange D, et al: Resection of hepatocellular carcinoma: results in 72 European patients with cirrhosis. Gastroenterology 1990;98:733-738.
41. Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K: A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery 2002;131:153-158.
42. Makuuchi M, Imamura H, Sugawara Y, Takayama T: Progress in surgical treatment of hepatocellular carcinoma. Oncology 2002;62:74-81.
43. Llovet JM, Fuster J, Bruix J: Intention-totreat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999;30:1434-1440.
44. Qian J, Feng GS, Vogl T: Combined interventional therapies of hepatocellular carcinoma. World J Gastroenterol 2003;9:1885-1891.
45. Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, et al: Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004;40:1352-1360.
46. Ryder SD, Rizzi PM, Metivier E, Karami J, Williams R: Chemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinoma. Gut 1996;38:125-128.